Median Technologies SA (MEDIAN TECHNOLOGIES) Aktie

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imaging Lab. Also, the company focuses on the oncology clinical trials market and the cancer patient care market. The company was founded in 2002 and is based in Valbonne, France.